Ensysce Biosciences ENSC
NASDAQ ENSC
$0.51 -0.01 (-1.92%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Long-Term Deferred Tax (2019)

Updated

Ensysce Biosciences' Long-Term Deferred Tax was $110.00 in Q1 2019.

Analysis

Ensysce Biosciences (ENSC) Long-Term Deferred Tax (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Ensysce Biosciences 1.30 Mn -10.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 110.00
API Access

Ensysce Biosciences Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ENSC&period=max&api_key=YOUR_API_KEY